Evidence map›Paper›PMID 25562651›Full record

ReviewJournal of personalized medicine2013

Effect model law: an approach for the implementation of personalized medicine.

Jean-Pierre Boissel, Riad Kahoul, Draltan Marin, François-Henri Boissel

Abstract readReview
In one paragraph

Review in Journal of personalized medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. In Silico Clinical Trials: Is It Possible?Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Bridging Systems Medicine and Patient Needs.CPT: pharmacometrics & systems pharmacology · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jean-Pierre BoisselNovadiscovery SAS, 60 Avenue Rockefeller, Lyon 69008, France. jean-pierre.boissel@novadiscovery.com.
Riad KahoulNovadiscovery SAS, 60 Avenue Rockefeller, Lyon 69008, France. riad.kahoul@novadiscovery.com.
Draltan MarinNovadiscovery SAS, 60 Avenue Rockefeller, Lyon 69008, France. draltan.marin@novadiscovery.com.
François-Henri BoisselNovadiscovery SAS, 60 Avenue Rockefeller, Lyon 69008, France. francois.boissel@novadiscovery.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The effect model law states that a natural relationship exists between the frequency (observation) or the probability (prediction) of a morbid event without any treatment and the frequency or probability of the same event with a treatment. This relationship is called the effect model. It applies to a single individual, individuals within a population, or groups. In the latter case, frequencies or probabilities are averages of the group. The relationship is specific to a therapy, a disease or an event, and a period of observation. If one single disease is expressed through several distinct events, a treatment will be characterized by as many effect models. Empirical evidence, simulations with models of diseases and therapies and virtual populations, as well as theoretical derivation support the existence of the law. The effect model could be estimated through statistical fitting or mathematical modelling. It enables the prediction of the (absolute) benefit of a treatment for a given patient. It thus constitutes the theoretical basis for the design of practical tools for personalized medicine.

Identifiers

PMID25562651
PMCPMC4251395

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.